about
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data.Single brain metastasis: radiosurgery alone compared with radiosurgery plus up-front whole-brain radiotherapy.Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases.Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer.Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1-3 brain metastases: results of a matched pair analysis.Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases.Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.Dose escalation of whole-brain radiotherapy for brain metastases from melanoma.Endpoints in phase II trials for advanced non-small cell lung cancer.Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?Shorter-course whole-brain radiotherapy for brain metastases in elderly patients.Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer.A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422).A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.The role of radiotherapy after radical prostatectomy.Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.Malignant pineal parenchymal tumors in adult patients: patterns of care and prognostic factors.Rectal cancer: Preoperative versus postoperative irradiation as a component of adjuvant treatment.Radiotherapy for a rising PSA following radical prostatectomy.Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy.Breast-conserving therapy and sentinel lymph node biopsy are feasible in cancer patients with previous implant breast augmentation.Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.The clinical case for proton beam therapy.Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases.A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904.Role of radiation therapy in the treatment of melanoma.The role of postoperative radiotherapy for the treatment of gangliogliomas.Treatment of painful bone metastases.Malignant epidural spinal cord compression: the role of external beam radiotherapy.Risk of radiation retinopathy in patients with orbital and ocular lymphoma.Charged particle radiation therapy for uveal melanoma: a systematic review and meta-analysis.Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer.A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone.Metastatic spinal cord compression in non-small cell lung cancer patients. Prognostic factors in a series of 356 patients.
P50
Q30627447-0444569A-76AA-4A77-8F68-FA2A2BD6E3CDQ31039691-4AEB6E0E-7580-4F7D-B6EB-FA7DC80FA38FQ33284025-37EA4194-1760-49E9-AE70-EC80CFEB346DQ33291831-A74155FA-8E19-4C99-B0FB-76F156F8C37CQ33300250-0610B7E8-52FE-4591-8A19-AA6AEA459A1FQ33301921-279A4520-C99F-4962-B09B-4BC905973F97Q33314337-0B0BB6AE-DE8A-434F-9E5C-A5F2BB2CC0B2Q33344354-AD7E7C7B-8F4E-4582-AD6A-3112E7745203Q33390644-0C27FDE6-956E-4F4F-B059-944A684BCA14Q33395704-81829D11-83E8-41EF-894D-970EA9AE209FQ33436297-8BC01A77-CAE5-47D7-ACAD-BB644A50B986Q33500429-7DFF9F40-CD02-44BF-B105-001C1BC26EB8Q33557040-3DB751DD-F468-4951-B90F-DDBB1F74CE3CQ33582983-6DB2964F-99F8-4271-83A3-385305A76E88Q33866703-D95DFB20-0BAA-4BE7-963C-5F0E032AF56CQ34196497-77945690-9FED-477F-BFE0-265BCEF061F8Q34307930-420313E0-192A-4DB6-8EAF-95466B08D025Q34322552-2A2B6897-32DD-4111-961E-843256DDC04BQ34323959-166CAC5E-1F18-498D-B3F6-A392CF9D23B1Q34394914-AAB8234C-AC0F-4808-8FDC-928B85FAB5C1Q34666837-0D1E0682-4D1B-4BA6-B559-009FA034D74CQ34666843-A38E2290-80F7-41FC-9C3A-02DA9029DE2FQ34786628-EBB5BA67-E6E7-4388-9C92-B489F39F1E42Q35572006-E22B5ED2-B41C-4971-9E14-3C13B292CE8CQ35669933-B652AB2F-9907-4F7E-BD07-89111D72A41DQ35721466-53E523E5-F2BA-41FF-A43E-AD34652F3F23Q35833919-84907332-71F7-4F59-BAEE-7B529F86ACA5Q36134711-8C117C66-A05E-4781-813A-9241EC04FF14Q36547835-E3F53E7B-2FD2-4E60-87EB-1295BB8BB73AQ36694774-41086A21-71EF-42E0-8FEB-AA26DEB75CF5Q37293955-BD8C0876-9E2D-4E0A-A3F1-317ECCC0EA92Q37483955-1611CB44-2CC6-4D75-81DE-9591A74671FAQ37631541-B1A470D6-DA36-4A96-B1B8-4528C48C9BF5Q37710370-81235C82-0EAA-450B-8711-A6BEC6675EF5Q37966745-572D8DC9-BC87-4312-9E5D-D30085CDD5E4Q38010577-40CE02AE-B048-4C68-93EB-22B8B1722E20Q38049690-E6D32F33-D6E7-45BF-8E13-93D73EDEB891Q38678764-F10529CC-FD63-4369-B049-E449183FD92AQ39390096-46BB2660-84F9-4FA6-9C69-121094C17309Q39648592-28000C79-1D8B-4483-97D3-24FAEBCFE31E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Steven E Schild
@ast
Steven E Schild
@en
Steven E Schild
@es
Steven E Schild
@nl
type
label
Steven E Schild
@ast
Steven E Schild
@en
Steven E Schild
@es
Steven E Schild
@nl
prefLabel
Steven E Schild
@ast
Steven E Schild
@en
Steven E Schild
@es
Steven E Schild
@nl
P106
P1153
7005583694
P21
P31
P496
0000-0002-2850-4126